<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The up-regulation of fucosyltransferase 8 (FUT8), the only enzyme catalyzing α1,6-fucosylation in mammals, has been observed in several malignant <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> including liver, ovarian, thyroid, and <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the pathological role and the regulatory mechanism of FUT8 in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> remain largely unknown </plain></SENT>
<SENT sid="2" pm="."><plain>In the current study, we report that the expression of FUT8 is up-regulated in <z:e sem="disease" ids="C0007131" disease_type="Neoplastic Process" abbrv="NSCLC">nonsmall cell lung cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NSCLC</z:e>) and correlates with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">tumor metastasis</z:e>, disease recurrence, and poor survival in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NSCLC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Knocking down FUT8 in aggressive <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> cell lines significantly inhibits their malignant behaviors including in vitro invasion and cell proliferation, as well as in vivo <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The results of glycoproteomic and microarray analyses show that FUT8 globally modifies surface antigens, receptors, and <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules and is involved in the regulation of dozens of genes associated with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, suggesting that FUT8 contributes to <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> through multiple mechanisms </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, we show that FUT8 is up-regulated during epithelial-mesenchymal transition (EMT), a critical process for <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, via the transactivation of β-catenin/lymphoid enhancer-binding factor-1 (LEF-1) </plain></SENT>
<SENT sid="6" pm="."><plain>These results provide a model to illustrate the relation between FUT8 expression and <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> progression and point to a promising direction for the prognosis and therapy of <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> </plain></SENT>
</text></document>